Roper Q3 revenue up 22% to $1.46B; adjusted DEPS $3.91; announces three divestitures

ROPER TECHNOLOGIES INC

2021-Q3 EPS reported $8.13 revenue$4,265,500,000

Continuing ops: revenue $1.46B (+22% GAAP, +12% organic); EBITDA $558M (+21%).
GAAP DEPS (incl. disc. ops) $2.71; adjusted DEPS $3.91; operating cash flow $447M.
Definitive agreements to divest TransCore, Zetec, and CIVCO Radiotherapy (now discontinued ops).
FY2021 continuing ops adjusted DEPS guidance $14.08-$14.12; Q4 adj DEPS $3.62-$3.66.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.